Effect of radiotherapy on T cell and PD-1 / PD-L1 blocking therapy in tumor microenvironment
Cancer is a worldwide problem that threatens human health. Radiotherapy plays an important role in a variety of cancer treatment methods. The administration of radiotherapy can alter the differentiation pathways and functions of T cells, which in turn improves the immune response of T cells. Radioth...
Main Authors: | Chen Chen, Yanlong Liu, Binbin Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-06-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1840254 |
Similar Items
-
Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
by: Young Wha Koh, et al.
Published: (2023-03-01) -
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma
by: Holger H. Göbel, et al.
Published: (2022-05-01) -
PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
by: Jun Wang, et al.
Published: (2017-01-01) -
Tumor‐associated macrophages regulate the function of cytotoxic T lymphocyte through PD‐1/PD‐L1 pathway in multiple myeloma
by: Jiangbo Zhang, et al.
Published: (2022-12-01) -
Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
by: Mengdi Fu, et al.
Published: (2025-02-01)